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a  b  s  t  r  a  c  t
Objective: There is evidence that standard assessment techniques for detecting PAD might
be  of less diagnostic accuracy in people with type 2 diabetes. The aim of this study was to
examine diagnostic performance of Plethysmographic-and-Doppler derived ankle brachial
index, toe brachial index, and Pulse volume waveform analysis for detecting PAD in people
with T2DM.
Methods: In this cross-sectional study 303 patients with T2DM were included in the study. The
participants underwent ABI measurement, applying both Plethysmographic and Doppler
derived devices, as well as TBI, PVW was also recorded for each patient. Diagnostic perfor-
mance of each test for detecting PAD, applying ultrasound Doppler scan as the referenceerived ankle brachial index (ABI)
oe brachial index (TBI)
standard, was measured. Moreover, the best cut-off point for each method to detect PAD
was  determined.
Results: PVW showed the highest sensitivity (81.8%) for detecting PAD, followed by ABIDOPulse volume waveform (PVW)Please cite this article in press as: M.R. Babaei, et al., Non-invasive vascular assessment in people with type 2 diabetes: Diagnostic performance
of Plethysmographic-and-Doppler derived ankle brachial index, toe brachial index, and pulse volume wave analysis for detection of peripheral
arterial disease, Prim. Care Diab. (2019), https://doi.org/10.1016/j.pcd.2019.09.005
eripheral arterial disease (PAD)
ype 2 diabetes (T2DM)
(72.7%), and ABIPLE (20%). However, all devices showed an excellent specificity for detecting
PAD.  The optimal cut-off point for diagnosis of PAD was 0.9 for ABIDOP, 1.2 for ABIPLE, and
0.38  for TBI.
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ali-asr Sq., Tehran, Iran.
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ttps://doi.org/10.1016/j.pcd.2019.09.005
751-9918/© 2019 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
ARTICLE IN PRESSPCD-831; No. of Pages 8
2  p r i m a r y c a r e d i a b e t e s x x x ( 2 0 1 9 ) xxx–xxx
Conclusion: Within this population of patients with T2DM, TBI less than 0.38 provided the
best sensitivity for detection of PAD followed by PVW, ABIDOP ≤ 0.9, and ABIPLE < 1.2.
©  2019 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.1.  Introduction
Peripheral arterial disease (PAD) is a highly prevalent, yet
underdiagnosed, condition [1]. Although frequently asymp-
tomatic, it is a leading cause of leg pain, claudication,
ulceration, gangrene, and even amputation. On the other
hand, patients with type 2 diabetes (T2DM) are more  likely to
develop PAD than do the non-diabetic subjects. Furthermore,
they are affected by more  severe and extensive form of the dis-
ease that tends to involve more  distal arteries, progress more
quickly, and also it is more  likely to lead to ischemic ulcera-
tion and amputation [2]. Ankle brachial index (ABI) measured
by hand-held or automated devices has been the foundation
of non-invasive vascular assessments for several years. Toe
brachial index (TBI) and analysis of pulse volume waveform
(PVW) are further used in certain conditions.
ABI is widely used as an initial non-invasive tool for detec-
tion of PAD. However, the diagnostic accuracy of ABI varies
according to the studied population, cut-off points, and the
techniques used to detect flow to ankle arteries. Doppler
ultrasound, despite some limitations, is primarily used for
measuring the ABI. The sensitivity and specificity of Doppler-
derived-ABI (ABIDOP) have been reported to widely range from
17% to 100% and 18% to 100%, respectively, with a lower sensi-
tivity among patients with diabetes [3]. Although an ABI ≤ 0.90
has been recommended by the American Heart Association
(AHA) and European Society of Cardiology (ESC) as the best
cut-off point both for detection of PAD and prediction of
cardiovascular disease (CVD) [3,4], studies conducted among
various populations proposed higher level of ABI as an opti-
mal  cut-off [5,6]. Furthermore, with regard to the threshold
of ≤0.90, ABI detection in patients with diabetes yielded the
sensitivity even as low as 70%, suggesting this test may be
affected by diabetic calcified arteries [7]. On the other hand,
automated devices for measurement of ABI have been recently
used to overcome such limitations of Doppler ultrasound
as being time-consuming and operator-dependent. However,
plethysmographic-based ABI (ABIPLE) has been reported to
have a specificity of >90% but a moderate sensitivity of <80%
for detection of PAD [8,9]. Moreover, the optimal cut-off point
for diagnosis of PAD is considerably higher than the threshold
of ≤0.90, traditionally used for ABIDOP [8,9].
The fact that ABI has considerable limitations including
inability to detect distally located PAD and being falsely ele-
vated and non-diagnostic in the presence of medial artery
calcification (MAC)  necessitates the need for a secondary
mode of assessment for diagnosis of PAD, especially in
patients with diabetes in whom both conditions are fre-
quently seen. As TBI is measured distally, it is more  likely toPlease cite this article in press as: M.R. Babaei, et al., Non-invasive vascula
of Plethysmographic-and-Doppler derived ankle brachial index, toe brachi
arterial disease, Prim. Care Diab. (2019), https://doi.org/10.1016/j.pcd.2019.
detect more  distal stenosis. Furthermore, digital vessels are
less likely to be affected by MAC [10]. These factors make
the TBI a more  sensitive test than ABI for detection of PADin patients with diabetes [11]. However, there are varying
levels of diagnostic accuracy and no strictly evidence-based
cut-off is recommended for TBI to diagnose PAD across the
current literature. Moreover, analysis of PVW is another non-
invasive diagnostic procedure utilized as an adjunct to ABI
measurement to identify PAD in patients suspected to MAC [9].
However, there is limited evidence regarding diagnostic accu-
racy of this method as well as feasibility of incorporating it into
routine practice for detection of PAD in patients with diabetes.
Due to the high prevalence of PAD in patients with diabetes
and the fact that a large proportion of patients with PAD are
asymptomatic, accurate non-invasive vascular assessment of
lower limbs for timely diagnosis of PAD is essential in these
patients. Diagnostic accuracy of various methods as well as
specific cut-off point for diagnosis of PAD in patients with
diabetes is not well-established. To the best of our knowl-
edge, no clinical study was performed to explore diagnostic
performance of various methods and cut-offs for detection
of PAD in people with T2DM. Thus, we  conducted this study
to examine and compare individual diagnostic performance
of Plethysmographic-and-Doppler derived ABI, TBI, and PVWs
analysis for detecting PAD in people with T2DM and also to
determine the best cut-off point for each method, using ultra-
sound Duplex scan (UDS) as the gold standard.
2.  Method
We conducted a cross-sectional study to determine the diag-
nostic performance of common non-invasive lower limb
vascular assessment techniques in people with T2DM for
detecting PAD. This study was carried out at Institute of
Endocrinology and Metabolism, on diabetic patients who  con-
cord with the criteria for assessment of PAD according to
American Diabetes Association (ADA) guidelines [12]. The fol-
lowing subjects were included: patients 50 years of age and
older, patients under 50 years of age who had other PAD risk
factors (namely smoking, hypertension, dyslipidemia, or dura-
tion of diabetes >10 years), and patients with symptoms or
signs of PAD including history of decreased walking speed,
leg fatigue, claudication, and abnormal pedal pulses [12].
Exclusion criteria were: inability to lay supine, cellulitis, lym-
phedema, thrombophlebitis, history of deep vein thrombosis
(DVT) during the preceding 6 months, congestive heart fail-
ure, history of Raynaud’s phenomenon, any known allergy to
applying gel, presence of a wound preventing Doppler probe
or ankle cuff placement, as well as previous bilateral mas-
tectomy preventing measurement of brachial blood pressure.
All participants provided a written informed consent priorr assessment in people with type 2 diabetes: Diagnostic performance
al index, and pulse volume wave analysis for detection of peripheral
09.005
to participation. The study was approved by the local ethics
committee according to the Declaration of Helsinki.
Prior to the arterial assessment procedures, participants
were asked to complete a brief questionnaire including demo-
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Table 1 – Grading of stenosis according to peak systolic
velocity ratio [17].




≥2 ≥50% PADp r i m a r y c a r e d i a b e t
raphic data (age, sex, duration of diabetes, smoking status),
nd drug history. Moreover, documented medical outcomes,
uch as coronary artery disease (CAD), stroke, hypertension
HTN), and retinopathy, were recorded. In the same session
easurement of blood pressure (BP), weight, and height as
ell as assessment for the presence or abscence of neu-
opathy were performed by an experienced nurse. Moreover,
lood sample was obtained for measurement of glycated
emoglobin(HbA1C), triglyceride (TG), total cholesterol (chol),
ow density lipoprotein (LDL), high density lipoprotein (HDL),
nd creatinine(cr). Estimated glomerular filtration rate (e GFR)
as calculated according to cockcroft and gault formula”
Cr = {((140-age)*weight)/72*Cr)}*0.85(if female)”.
The participants were asked to avoid caffeine, smok-
ng, and exercise about 2 h prior to the examination to
revent influencing pressure measurements [13]. Room tem-
erature was monitored with a thermometer and was
aintained between 23 ◦C and 25 ◦C to prevent vasocon-
triction of digital arteries [3]. Next, while supine, each
articipant underwent ABI measurement, using both the auto-
ated plethysmographic device (Dopplex Ability (DA100PB),
untleigh Healthcare, Cardiff, UK) and Doppler ultrasound
LifeDop 150; Summit Doppler, Wallach Surgical Devices, Turn-
ull, Conn) with hand-held sphygmomanometer [14], as well
s bilateral TBI using Doppler ultrasound (LifeDop 150; Sum-
it  Doppler, Wallach Surgical Devices, Turnbull, Conn). The
lethysmographic device was used according to the manufac-
ure’s guideline and was undertaken first because there is no
eed for rest period before testing [15]. The device contains
ual chamber cuffs. The upper chamber occludes the arte-
ial blood flow and the lower chamber detects the returning
ulsation while the pressure in the upper chamber is grad-
ally reduced. The device measures the systolic pressure of
ll four limbs simultaneously and calculates an ABI for each
eg automatically. It also provides a 5-s strip of PVWs for each
eg. Like the phases of the cardiac cycle, PVW shows a sharp
eak, occurring during the systole, and a gradual downslope,
ccurring in diastole, with a dicortic notch, representing the
eflected blood flow. To qualitatively interpret the PVW, both
he contour and amplitude of the waveform should be taken
nto account. Absence of the dicortic notch and reduction in
he waveform amplitude represent arterial occlusion proximal
o the point at which the recording is taken. Interpretation of
VWs can be undertaken by visually comparing them to a four-
evel grading system [16]. Then after 5 min  ABI was measured
sing Doppler ultrasound in accordance with the American
eart Association’s scientific statement for ABI measurement
14]. For this purpose, bilateral brachial systolic pressures and
oth dorsalis pedis and posterior tibial artery pressure in each
imb were obtained using a hand-held sphygmomanometer.
ll measurements were undertaken by a trained nurse with
n extensive experience in vascular assessment of the lower
imbs. Not to influence the subjective Doppler measurements,
he examiner was blinded to the results of the automated
evice. Afterward toe systolic pressure was measured by plac-
ng a 2-cm-wide pneumatic cuff around the proximal phalanxPlease cite this article in press as: M.R. Babaei, et al., Non-invasive vascula
of Plethysmographic-and-Doppler derived ankle brachial index, toe brachi
arterial disease, Prim. Care Diab. (2019), https://doi.org/10.1016/j.pcd.2019.
f the great toe. The cuff was inflated to 20 mmHg  above the
ast signal. The cuff was then slowly deflated, the pressure was
ecorded when the onset of flow was detected with a DopplerNo color flow Complete occlusion PAD
PSV; peak systolic velocity, PAD; peripheral arterial disease.
ultrasound probe placed over the lateral side of toe. Subse-
quently PVWs obtained from automated plethysmographic
device were graded by an experienced clinician, blinded to
the results of ABI, in accordance with Rumwell and McPhar-
lin’s grading system [16]. ABIDOP in each leg was calculated
by dividing the higher of the posterior tibialis (PT) or dor-
salis pedis (DP) pressure by the higher of the right or left arm
systolic blood pressure (SBP) [14]. TBI in each leg was calcu-
lated by dividing the toe pressure by the higher of the right
or left arm SBP. In the same session, DUS of both lower limbs’
arteries were performed by a highly experienced sonographer
(equipment utilized: E Zaote C-class) who was blinded to the
results of ABI, TBI, and PVWs. UDS of both lower limbs’ arteries
were performed for all participants from the iliac and com-
mon  femoral arteries (CFA) then continued distally assessing
superficial femoral artery (SFA), popliteal, and tibial arteries in
the longitudinal plane. The extent and severity of any arterial
disease were assessed using triplex mode by measuring the
peak systolic velocity (PSV) from the Doppler waveform just
proximal to and through the stenosis. Disease severity was
classified using standard criteria outlined in Table 1 [17].
2.1.  Data  analysis
For the purpose of this study the result of each test for each
limb was included to determine the presence of PAD [14].
UDS was used as the reference standard because it has been
illustrated to be a valid, non-invasive imaging technique for
diagnosis of PAD due to the higher effectiveness at a lower
cost [18]. PAD was defined as any arterial stenosis of ≥50%
[17]. Sensitivity and specificity values of the ABIDOP, ABIPLE,
and TBI for the detection of PAD were calculated using the
standard cut-off score for an abnormal ABI (≤0.9) [3], as well
as an abnormal TBI (<0.64). To determine the sensitivity and
specificity of PVWs for the purpose of this study, they were
considered as normal (grade A) and abnormal (grade B, C, D)
(Fig. 1) [16].
2.2.  Statistical  analysis
The differences in baseline characteristics between the PAD
and non-PAD patients were evaluated using the t-test or Mann
Whitney test, depending on the data to be distributed nor-
mally or non-normally, respectively. Moreover, association
between the categorical variables was assessed using the Chi-
square test. To consider the prediction ability of ABI and TBIr assessment in people with type 2 diabetes: Diagnostic performance
al index, and pulse volume wave analysis for detection of peripheral
09.005
scores, logistic regression models were fitted, utilizing the PAD
and non-PAD status as the response. This model fitting pro-
vided area under the ROC curve, cut-off values, sensitivity, and
specificity of the studied clinical tools.
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on (aFig. 1 – Pulse volume waveform interpretati
3.  Results
Considering the prevalence of PAD in patients with diabetes,
a total sample of 303 patients with T2DM (606 limbs) were
included in the final analysis. The mean age of the partic-
ipants was 60.07 ± 0.34 years and 39.8% of them were male.
Mean duration of diabetes was 13.29 ± 0.34 years. In total, 2.2%
of the participants were found to have PAD defined by DUS
as the reference standard. PAD was demonstrated to be pos-
itively associated with history of smoking (p = 0.000), known
CAD (p = 0.01), presence of retinopathy (p = 0.02) and neuropa-
thy (p = 0.000), history of claudication (p = 0.000), rest pain
(p = 0.01), and foot ulcer (p = 0.000). Moreover, PAD patients
showed to have higher levels of total cholesterol (p = 0.04), LDL
(p = 0.02), and a lower level of HDL (p = 0.000). Furthermore,
mean level of ABIDOP (0.89 vs 1.10, p = 0.002) as well as that
of TBI (0.26 vs 0.76, p = 0.000) were significantly lower in PAD
patients. However, there was no significant difference between
mean ABIPLE of patients with and without PAD (1.12 vs 1.12)
(Table 2).
The sensitivity and specificity of the ABIDOP, ABIPLE, PVW
analysis, and TBI for detection of PAD, based on standard cut-
off values, compared to the UDS as the reference standard,
are presented in Table 3. PVW showed the highest sensitiv-
ity (81.8%) for detecting PAD, followed by ABIDOP (72.7%), and
ABIPLE (20%). Moreover, all devices showed an excellent speci-
ficity for detecting PAD including 95.8% for ABIDOP, 95.6% for
ABIPLE, and 93.2% for PVW. All methods show overall accuracyPlease cite this article in press as: M.R. Babaei, et al., Non-invasive vascula
of Plethysmographic-and-Doppler derived ankle brachial index, toe brachi
arterial disease, Prim. Care Diab. (2019), https://doi.org/10.1016/j.pcd.2019.
of more  than 98%. However, we  could not obtain the diagnos-
tic accuracy of TBI, applying the cut-off value of 0.64, due to
the small number of PAD events.ccording to four-level grading system) [16].
ROC curve analysis was performed to determine the best
cut-off value for ABIDOP, ABIPLE, and TBI for detection of PAD
in this population of patients with diabetes (Fig. 2). The results
were as follow: the area under curve (AUC) was 0.99 (95% con-
fidence interval (CI): 0.97–0.99, p-value = 0.000) for TBI, 0.78
(95% CI: 0.74–0.81, p-value = 0.02) for ABIDOP, and 0.48 (95% CI:
0.44–0.52, p-value = 0.8) for ABIPLE. The optimal cut-off point
for diagnosis of PAD was 0.90 for ABIDOP, 1.2 for ABIPLE, and
0.38 for TBI provided the sensitivity of 72.2%, 40% and 100%, as
well as the specificity of 95.8%, 79.9%, and 95.8%, respectively
(Supplementary Table 1).
The sensitivity, specificity, and overall accuracy of com-
bined ABIPLE and PVW analysis are presented in the
Supplementary Table 2. The results show an increase in
the sensitivity (75%), specificity (97.5%), and overall accuracy
(96.7%) of ABIPLE combined with PVW analysis.
4.  Discussion
4.1.  The  ABI
Assessment of diagnostic performance of ABIDOP ≤ 0.9 to
detect significant (≥50%) arterial stenosis identified by UDS
revealed sensitivity of 72.7%, and specificity of 95.8%, in this
population of patients with T2DM. Moreover, ROC curve anal-
ysis of Doppler-derived ABI to determine the best cut-off value
for detection of ≥50% stenosis identified by UDS in this pop-r assessment in people with type 2 diabetes: Diagnostic performance
al index, and pulse volume wave analysis for detection of peripheral
09.005
ulation of patients with diabetes showed the value of 0.9 as
the best threshold provided sensitivity of 72.7% and speci-
ficity of 95.8%. These findings confirm the results of previous
studies which recommend the ABIDOP ≤ 0.9 to be considered
ARTICLE IN PRESSPCD-831; No. of Pages 8
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Table 2 – Baseline characteristics of the participants.
Variable Total (n = 606) PAD (n = 13) No PAD (n = 593) P value
Age (year) 60.07 (0.34) 60.00 (1.92) 60.08 (0.34) 0.85*
Sex (%M) 39.8 61.5 39.3 0.10
Duration of diabetes (year) 13.29 (0.34) 16.38 (2.62) 13.19 (0.34) 0.17*
Smoking status (%)
Never 93.1 53.8 93.9 0.000
Current 4.6 38.5 3.9
Past 2.3 7.7 2.2
Known CAD (%) 12.5 38.5 12.0 0.01
Known stroke (%) 1.6 7.7 1.5 0.19
Known HTN (%) 69.7 84.6 69.3 0.38
Retinopathy (%) 21.1 46.2 20.2 0.02
Neuropathy (%) 42.8 100.0 41.3 0.000
Claudication (%) 17.1 61.5 15.9 0.000
Rest pain (%) 20.1 46.2 19.3 0.01
Foot ulcer (%) 6.6 46.2 5.4 0.000
Vascular surgery (%) 17.4 38.5 17.0 0.04
Use of ASA (%) 81.3 100 80.8 0.14
Use of statin (%) 90.1 84.6 90.2 0.37
SBP (mmHg) 131.45 (0.84) 130 (5.46) 131.56 (0.85) 0.94*
DBP (mmHg) 77.79 (0.42) 80 (3.00) 77.75 (0.43) 0.62*
HbA1C (%) 7.76 (0.07) 7.23 (0.84) 7.77 (0.07) 0.69*
TG (mg/dl) 136.7(2.96) 152 (14.62) 136.50 (3.01) 0.14*
Total chol (mg/dl) 138.75 (1.25) 159.08 (11.03) 138.25 (1.26) 0.04*
LDL (mg/dl) 68.71 (1.28) 87.54 (9.07) 68.21 (1.29) 0.02*
HDL (mg/dl) 44.16 (0.50) 34.46 (2.54) 44.39 (0.51) 0.00*
eGFR (ml/min/m2) 76.02 (1.01) 60.51 (7.95) 76.43 (1.01) 0.11*
Mean ABIDOP 1.09 (0.01) 0.89 (0.08) 1.10 (0.01) 0.002*
Mean ABIPLE 1.12 (0.001) 1.12 (0.10) 1.12 (0.01) 0.79*
Mean TBI 0.75 (0.01) 0.26 (0.04) 0.76 (0.01) 0.000*
PAD status according to Doppler ultrasound.
Mean (S.E.) for continuous variables.*Mann–Whitney test.
PAD; peripheral arterial disease, CAD; coronary arterial disease, HTN; hypertension, SBP; systolic blood pressure, DBP, diastolic blood pressure,
TG; triglyceride, LDL; low density lipoprotein, HDL; high density lipoprotein, eGFR; estimated glumerolar filtration rate, ABIDOP; doplor-derived
ankle brachial index, ABIPLE; plethysmographic-derived ankle brachial index, TBI; toe brachial index.
Table 3 – Diagnostic performance of different methods in detecting PAD based on standard cut-off values.
ABIDOP ≤ 0.9 (603 limbs) ABIPLE ≤ 0.9 (n = 603 limbs) PVW (grades B, C, D) (n = 603 limbs)
Sensitivity (%) 72.7 20 81.8


















Overall accuracy 98.3 98.3 
ABIDOP; Doppler-derived ankle brachial index, ABIPLE; Plethysmograph
s the optimal threshold for confirming the diagnosis of lower
xtremity PAD [3,4]. The diagnostic performance of ABIDOP in
his study is concordance with the results of previous studies
hich showed a high level of specificity but different levels of
ensitivity [3,18] with lower sensitivity levels in patients with
iabetes [3,7,19–21].
We also assessed diagnostic performance of
lethysmographic-based ABI ≤ 0.9 for detection of ≥50%
tenosis identified by UDS. The results demonstrated sensi-
ivity of 20% and specificity of 95.6%. ROC curve analysis of
lethysmographic-based ABI to discover the best cut-off value
or detection of ≥50% stenosis identified by UDS in people
ith T2DM showed the value of 1.2 as the optimal threshold
rovided sensitivity of 40% and specificity of 79.9%. ThePlease cite this article in press as: M.R. Babaei, et al., Non-invasive vascula
of Plethysmographic-and-Doppler derived ankle brachial index, toe brachi
arterial disease, Prim. Care Diab. (2019), https://doi.org/10.1016/j.pcd.2019.
act that higher ABIPLE cut-off value yielded higher level of
ensitivity for detection of PAD has been frequently reported
y previous studies [8,9]. However, our findings suggest higher98.2
rived ABI, PVW; pulse velocity wave.
cut-off value with lower sensitivity and specificity compared
to previous studies. This could be explained by the baseline
characteristics of our studied population that only included
patients with T2DM who were more  likely to be affected by
calcified arteries. Such incompressible arteries can artfactu-
ally raise ankle systolic pressures in patients with PAD, lead
to higher levels of ABI within the normal range, and make the
ABI less diagnostic in such a population. Moreover, the higher
Plethysmographic-based ABI yet yielding the lower diagnostic
performance compared to Doppler-derived ABI is a common
finding associated with automated devices [22,23].
4.2.  PVW  analysisr assessment in people with type 2 diabetes: Diagnostic performance
al index, and pulse volume wave analysis for detection of peripheral
09.005
Data suggest that analysis of PVW has good sensitivity (81.8%)
and high specificity (93.2%) to detect PAD, providing better sen-
sitivity compared to ABI. Although there are limited studies
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Fig. 2 – ROC analysis of TBI, ABIDOP, and ABIPLE for
detecting PAD as defined by ultrasound Doppler scan. AUC
for ABIDOP = 0.78 (95% CI: 0.74–0.81, p-value = 0.02), AUC for
ABIPLE = 0.48 (95% CI: 0.44–0.52, p-value = 0.8), AUC for
TBI = 0.99 (95% CI: 0.97–0.99, p-value = 0.000).
ROC; receiver operating curve, TBI; toe brachial index,
ABIDOP; Doppler-derived ankle brachial index, ABIPLE;
plethysmographic-derived ABI.
drawn that TBI and qualitative waveform analysis are more
effective screening methods than ABI for detection of PAD
in patients with T2DM. Furthermore, the results indicate
plethysmographic-derived ABI cannot provide sufficient diag-investigating the diagnostic performance of PVW analysis for
identification of PAD, the results are encouraging. A similar
study demonstrated PVW analysis provides an excellent sensi-
tivity for the detection of PAD while the ABI provided very good
specificity [9]. Moreover, Lewis et al. showed pulse volume
recording agrees well with color spectral waveforms, although
the agreement with ABI was less than 50% [24]. That PVW anal-
ysis indicates better diagnostic performance than does ABI
might be explained by the fact that the presence of calcified
vessels or limb edema does not influence the pulse volume
recording. This finding is well elucidated in a study by Davies
et al. [25]. They showed in the presence of MAC, artefactually
raising the ABI to normal or even high normal levels, analysis
of PVW can be easily applied to identify patients who suffer
from arterial insufficiency and may benefit from further vascu-
lar assessment and intervention [25]. Physiologically speaking,
PVW represents the total blood flow through the examined
area, not being able to provide accurate diagnostic informa-
tion on where and to what extent a specific artery is diseased.
In the other words, a normal waveform in patients with sig-
nificant arterial stenosis indicates good collateral blood flow,
making PVW analysis a useful tool in assessing whether a
lower extremity wound has sufficient arterial blood supply to
facilitate healing.Please cite this article in press as: M.R. Babaei, et al., Non-invasive vascula
of Plethysmographic-and-Doppler derived ankle brachial index, toe brachi
arterial disease, Prim. Care Diab. (2019), https://doi.org/10.1016/j.pcd.2019.x x x ( 2 0 1 9 ) xxx–xxx
4.3.  Combining  ABIPLE and  PVW  analysis
Combination of abnormal PVW results for each participant
with normal or high normal ABIPLE results showed an increase
in the diagnostic accuracy of this method. This finding high-
lights the usefulness of a dual diagnostic device for diagnosis
of PAD in patients with diabetes.
4.4.  The  TBI
Applying TBI cut-off of 0.64, we  found the test is not able to
correctly detect PAD. ROC curve analysis of TBI to discover the
best cut-off value for detection of significant stenosis (≥50%)
identified by UDS demonstrated the value of 0.38 is the best
cut point for detection of PAD in this population providing a
sensitivity of 100% and specificity of 95.8%. On the contrary
to the well-defined and evidence-based ABI cut-off value, the
basis for diagnosis of PAD applying TBI cut-off value of 0.6 or
0.7 is not well referenced. There are some evidences that a
proportion of people with TBI > 0.6 have been shown to have
PAD according to the imaging studies [26]. To the best of our
knowledge, the best cut-off value for TBI to detect PAD in a
population of patients with T2DM has not been previously
reported. Considering our results, TBI cut-off of less than 0.38
could be used as an accurate screening measure in high risk
limbs.
4.5.  Study  strength  and  limitations
To the best of our knowledge, it is the first study assessed the
diagnostic performance of all screening methods for detection
of PAD in a population of patients with T2DM. Moreover, this
study has utilized UDS, as the reference standard, which is rec-
ognized to be a non-invasive modality with excellent accuracy
for diagnosis of PAD. Furthermore, most studies conducted to
determine the diagnostic accuracy of these screening methods
included severe cases of PAD, while we included a population
of patients with diabetes who were eligible for vascular screen-
ing based on current ADA guidelines. Therefore, the results
could be generalized to the majority of people with T2DM.
However, this leaves a limitation in that despite an adequately
large samples, only a small proportion (2.2%) of participants
were found to have PAD. Moreover, lack of standardized pretest
limb heating could partly explain the low average TBI found
in this study and may compromise the reproducibility of the
result.
5.  Conclusion
Within this population of patients with T2DM, TBI less than
0.38 provided the best sensitivity for detection of PAD fol-
lowed by PVW, ABIDOP ≤ 0.9, and ABIPLE < 1.2. With regard to
the specificity, all diagnostic methods yield excellent results
but for plethysmographic-derived ABI which provides a mod-
erate specificity of 79.9%. The following conclusion may ber assessment in people with type 2 diabetes: Diagnostic performance
al index, and pulse volume wave analysis for detection of peripheral
09.005
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p r i m a r y c a r e d i a b e t
ostic performance for diagnosis of PAD as a standalone test.
owever, applying the threshold of 1.2, this device can be used
s a fast method to identify patients who require further arte-
ial assessment using PVW analysis, Doppler-derived ABI, or
BI.
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